Unknown

Dataset Information

0

Shengmai Formula suppressed over-activated Ras/MAPK pathway in C. elegans by opening mitochondrial permeability transition pore via regulating cyclophilin D.


ABSTRACT: Since about 30% of all human cancers contain mutationally activated Ras, down regulating the over-activation of Ras/MAPK pathway represents a viable approach for treating cancers. Over-activation of Ras/MAPK pathway is accompanied by accumulation of reactive oxygen species (ROS). One approach for developing anti-cancer drugs is to target ROS production and their accumulation. To test this idea, we have employed C. elegans of let-60 (gf) mutant, which contain over-activated let-60 (the homolog of mammalian ras) and exhibit tumor-like symptom of multivulva phenotype, to determine whether anti-oxidants can affect their tumor-like phenotype. Specifically we studied the effect of Shengmai formula (SM), a traditional Chinese medicine that has strong anti-oxidant activity, on the physiology of let-60 (gf) mutants. Unexpectedly, we found that SM treatment led to the opening of mitochondrial permeability transition pore by regulating cyclophilin D and then triggered oxidative stress and related signaling pathway activation, including p53, JNK, and p38/MAPK pathways. Finally, SM induced mitochondrial pathway of apoptosis and inhibited the tumor-like symptom of the multivulva phenotype of let-60(gf) mutants. Our results provide evidences to support that SM act as a pro-oxidant agent and could serve as a potential drug candidate for combating over-activated Ras-related cancer.

SUBMITTER: Liu Y 

PROVIDER: S-EPMC5159904 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Shengmai Formula suppressed over-activated Ras/MAPK pathway in C. elegans by opening mitochondrial permeability transition pore via regulating cyclophilin D.

Liu Yan Y   Zhi Dejuan D   Li Menghui M   Liu Dongling D   Wang Xin X   Wu Zhengrong Z   Zhang Zhanxin Z   Fei Dongqing D   Li Yang Y   Zhu Hongmei H   Xie Qingjian Q   Yang Hui H   Li Hongyu H  

Scientific reports 20161216


Since about 30% of all human cancers contain mutationally activated Ras, down regulating the over-activation of Ras/MAPK pathway represents a viable approach for treating cancers. Over-activation of Ras/MAPK pathway is accompanied by accumulation of reactive oxygen species (ROS). One approach for developing anti-cancer drugs is to target ROS production and their accumulation. To test this idea, we have employed C. elegans of let-60 (gf) mutant, which contain over-activated let-60 (the homolog of  ...[more]

Similar Datasets

| S-EPMC7177490 | biostudies-literature
| S-EPMC11482344 | biostudies-literature
| S-EPMC7438327 | biostudies-literature
| S-EPMC7054270 | biostudies-literature
| S-EPMC9043413 | biostudies-literature
| S-EPMC6397958 | biostudies-literature
| S-EPMC4430462 | biostudies-literature
2024-06-01 | GSE248639 | GEO
| S-EPMC6538282 | biostudies-literature
2024-06-01 | GSE248635 | GEO